HomeNewsTrendsHealthIIT Delhi researchers develop RT-PCR based assay for detection of Omicron variant within 90 minutes

IIT Delhi researchers develop RT-PCR based assay for detection of Omicron variant within 90 minutes

Currently, the identification or screening for Omicron is done worldwide using next-generation sequencing-based methods which require over three days.

December 13, 2021 / 22:18 IST
Representative image: AP

Researchers at the Indian Institute of Technology (IIT), Delhi have developed an RT-PCR based assay for the specific detection of the Omicron variant of COVID-19 within 90 minutes, according to officials.

Currently, the identification or screening for Omicron is done worldwide using next-generation sequencing-based methods which require over three days.

The institute has filed an Indian patent application for the rapid screening assay developed by its Kusuma School of Biological Sciences and is in process of initiating talks with potential industry partners.

"The assay is based on detecting specific mutations which are present in the Omicron variant and absent in other currently circulating variants of SARS-CoV-2. Primer sets targeting these unique mutations in the S gene were designed for the specific amplification of either the Omicron variant or other currently circulating variants of SARS-CoV-2 and tested using real time PCR," a senior IIT Delhi official said.

"Using synthetic DNA fragments, the assays were optimised to distinguish the wild-type from the Omicron variant in a dynamic range. Currently, the identification or screening for Omicron is done worldwide using next-generation sequencing based methods, which require over 3 days. By using this RT-PCR based assay, it will be possible to test for the presence of the Omicron variant within 90 minutes," the official added.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

IIT Delhi was the first academic institute in India to have obtained ICMR approval for a real-time PCR-based diagnostic assay. The institute developed a method to detect COVID-19 which significantly reduced the cost of testing, making it affordable for a large population in the country.

Following approval from the ICMR, the kit was successfully launched in the market.

The Omicron variant was first detected in India in Bengaluru with two people testing positive for it.

Kerala, Andhra Pradesh and Chandigarh reported their first Omicron case on Sunday, while Maharashtra and Karnataka each recorded one more case of the COVID-19 variant, taking the tally in the country to 38.

Cases of Omicron, which is categorised as a "variant of concern" by the World Health Organisation, have been detected in about 60 countries.

PTI
first published: Dec 13, 2021 10:18 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347